Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$3.76 - $6.29 $1,880 - $3,145
500 Added 1.1%
45,830 $256,000
Q1 2022

May 12, 2022

SELL
$5.03 - $9.61 $492 - $941
-98 Reduced 0.22%
45,330 $280,000
Q4 2021

Feb 10, 2022

SELL
$8.12 - $10.37 $167,288 - $213,642
-20,602 Reduced 31.2%
45,428 $406,000
Q3 2021

Nov 12, 2021

BUY
$7.48 - $11.38 $20,196 - $30,726
2,700 Added 4.26%
66,030 $642,000
Q2 2021

Aug 06, 2021

SELL
$7.16 - $9.56 $35,800 - $47,800
-5,000 Reduced 7.32%
63,330 $523,000
Q1 2021

May 10, 2021

BUY
$8.52 - $19.21 $216,578 - $488,318
25,420 Added 59.24%
68,330 $652,000
Q4 2020

Feb 10, 2021

BUY
$9.3 - $15.19 $84,630 - $138,229
9,100 Added 26.92%
42,910 $400,000
Q3 2020

Nov 13, 2020

SELL
$8.24 - $30.8 $106,988 - $399,907
-12,984 Reduced 27.75%
33,810 $459,000
Q2 2020

Aug 10, 2020

BUY
$7.46 - $23.42 $104,387 - $327,716
13,993 Added 42.66%
46,794 $905,000
Q1 2020

May 21, 2020

SELL
$0.91 - $17.81 $90,272 - $1.77 Million
-99,201 Reduced 75.15%
32,801 $250,000
Q4 2019

Feb 14, 2020

BUY
$0.88 - $1.12 $1,760 - $2,240
2,000 Added 1.54%
132,002 $118,000
Q2 2019

Aug 13, 2019

BUY
$0.71 - $1.17 $10,650 - $17,550
15,000 Added 13.04%
130,002 $107,000
Q1 2019

May 15, 2019

BUY
$0.96 - $2.24 $20,160 - $47,040
21,000 Added 22.34%
115,002 $122,000
Q4 2018

Feb 14, 2019

BUY
$1.15 - $2.61 $18,929 - $42,960
16,460 Added 21.23%
94,002 $138,000
Q2 2018

Aug 14, 2018

SELL
$1.62 - $5.28 $34,830 - $113,520
-21,500 Reduced 21.71%
77,542 $301,000
Q1 2018

May 15, 2018

BUY
$1.56 - $3.2 $2,340 - $4,800
1,500 Added 1.54%
99,042 $216,000
Q4 2017

Feb 14, 2018

BUY
$2.38 - $6.72 $68,284 - $192,803
28,691 Added 41.67%
97,542 $265,000
Q3 2017

Nov 14, 2017

BUY
$3.85 - $6.3 $265,076 - $433,761
68,851
68,851 $430,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $24.7M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.